News

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...
Parkinson’s disease is increasingly affecting younger Indians, with early-onset cases rising sharply. Experts warn that ...
Every year, in the month of April, World Parkinson’s Day serves as a powerful reminder of the challenges faced by millions ...
Parkinson’s disease is often described as bleak strokes, shaky hands, stiff limbs, a slow decline. But can movement be the ...
Saunas and hot yoga offer therapeutic heat exposure, enhancing cardiovascular health, brain function, and psychological well-being through ancient practices.
CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...
Results from Lundbeck's open-label portion of the Pacific trial saw bexicaserin able to elicit seizure reduction in treatment ...
Hirayama disease is a rare neurological disorder primarily affecting young males. This condition poses diagnostic challenges ...
Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant epilepsy.
Brian Fiske, chief scientist at The Michael J. Fox Foundation for Parkinson’s Research, which funded some of Dr ...
MADISON, Wis. - Bucky's Race for Rehab will take over Madison on Saturday morning. The race is sold out. The event by the UW-Madison Doctor of Physical Therapy Department serves as a fundraiser for ...
The 340B Drug Pricing Program was originally designed to help vulnerable patients access medications and care at reduced ...